Effect of Cytokine-induced Killer Cells for Stage I-II Malignant Gliomas
Clinical trial NCT02494804 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT02494804
- Sponsor
- The First People's Hospital of Changzhou
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2015-07-01
- Primary completion
- 2028-07-01
- Enrollment
- 80
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.